HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Notes Gaps In Alternative Test Methods, Stakeholder Viewpoints

This article was originally published in The Rose Sheet

Executive Summary

A European Chemicals Agency official suggests that alternative methods for assessing or predicting toxicological risks still have a ways to go "before we can dream about a future in an animal test-free world." Other agency reps expressed similar sentiments during an April 18 media briefing.

You may also be interested in...



Landmark EU Ruling: Animal-Tested Cosmetic Ingredients Not Banned Per Se

Firms cannot use safety data derived from third-country animal testing to substantiate product safety in accordance with the European Cosmetics Regulation, but such testing does not in itself constitute a violation of the EU’s animal-testing ban. It may be more challenging to compile required safety-assessment reports, but companies don’t necessarily have to choose between the EU and emerging markets such as China.

CIR’s 161st Expert Panel Meeting: Much Ado About Airbrush Cosmetics; Prostaglandins Make 2023 Priorities

Exactly what is in airbrush-delivered cosmetics, and how they are used by consumers, are not well understood by Cosmetic Ingredient Review, its expert panel, or the US FDA. At their June meeting, CIR’s independent experts debated who should be responsible for assessing airbrush cosmetics and how safety unknowns should be communicated.

CIR Expert Panel Announces New Blood Ahead Of 161st Meeting

Expect new faces in coming meetings of the US-based CIR’s Expert Panel for Cosmetic Ingredient Safety, which may tackle reviews of prostaglandin analogs and skin-lightening kojic acid on top of its usual slate of programmed safety assessments.

Topics

Latest News
UsernamePublicRestriction

Register

RS019886

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel